|1|Use of diffusion tensor imaging in assessing superficial myometrial invasion by endometrial carcinoma: a preliminary study. (25332442)
Zhang L.... Wang H.
|2|Relationship between PTEN, DNA mismatch repair, and tumor histotype in endometrial carcinoma: retained positive expression of PTEN preferentially identifies sporadic non-endometrioid carcinomas. (23599155)
Djordjevic B.... Broaddus R.R.
|3|Effects of ectopic HER-2/neu gene expression on the COX-2/PGE2/P450arom signaling pathway in endometrial carcinoma cells: HER-2/neu gene expression in endometrial carcinoma cells. (23453006)
Li S.... Yu Z.
|4|Secondary analyses from a randomized clinical trial: age as the key prognostic factor in endometrial carcinoma. (24361787)
Panici P.B.... Mangioni C.
|5|ETV5 cooperates with LPP as a sensor of extracellular signals and promotes EMT in endometrial carcinomas. (22266854)
Colas E.... Abal M.
|6|Evaluation of depth of myometrial invasion by magnetic resonance imaging in patients with endometrial carcinoma. (23185792)
Yayci E.... Suer N.
|7|Uterine endometrial carcinoma: 10 years' experience with long-term follow-up at a single Korean institution. (23075517)
Lee E.J.... Kim B.G.
|8|Markers for individualised therapy in endometrial carcinoma. (22846840)
Salvesen H.B.... Trovik J.
|9|Weekly paclitaxel-carboplatin regimen in patients with primary advanced or recurrent endometrial carcinoma. (22426408)
Vandenput I.... Amant F.
|10|Aberrant expression of the von Hippel-Lindau gene in human endometrial hyperplasia and endometrial carcinoma. (21436690)
Xu J.Y.... Wu J.
|11|Retrospective analysis on coexisting ovarian cancer in 976 patients with clinical stage I endometrial carcinoma. (21314805)
Pan Z.... Xie X.
|12|Phosphatase and tensin homolog gene inhibits the effect induced by gonadotropin-releasing hormone subtypes in human endometrial carcinoma cells. (20529558)
Zhao L.J.... Wei L.H.
|13|Mast cells: Are they really related to invasiveness of endometrial carcinoma? (20188490)
Erol Y.A.... Ozdemir O.
|14|Serum proteomic profile analysis for endometrial carcinoma detection with MALDI-TOF MS. (22371754)
Qiu F.... Zhang X.J.
|15|Enhanced CD24 expression in endometrial carcinoma and its expression pattern in normal and hyperplastic endometrium. (19130400)
Kim K.H.... Kim S.H.
|16|Molecular pathology of endometrial carcinoma: practical aspects from the diagnostic and therapeutic viewpoints. (18977806)
Llobet D.... Matias-Guiu X.
|17|Endometrial carcinoma clinical management: results of a regional survey. (20099502)
|18|Local biosynthesis of estrogen in human endometrial carcinoma through tumor-stromal cell interactions. (19789322)
Takahashi-Shiga N.... Yaegashi N.
|19|Management of surgical stage III and IV endometrioid endometrial carcinoma: an overview. (19407572)
van Wijk F.H.... van Doorn H.C.
|20|Inhibin-alpha subunit is an independent prognostic parameter in human endometrial carcinomas: analysis of inhibin/activin-alpha, -betaA and -betaB subunits in 302 cases. (19231155)
Mylonas I.... Friese K.
|21|CD10 immunostaining distinguishes atypical polypoid adenomyofibroma (atypical polypoid adenomyoma) from endometrial carcinoma invading the myometrium. (18619643)
Ohishi Y.... Tsuneyoshi M.
|22|Immunohistochemical bcl-2 expression, p53 overexpression, PR and ER status in endometrial carcinoma and survival outcomes. (18386458)
Kalogiannidis I.... Makedos G.
|23|An exploratory analysis of HER-2 amplification and overexpression in advanced endometrial carcinoma: a Gynecologic Oncology Group study. (17945336)
Grushko T.A.... Fleming G.F.
|24|Raloxifene, a selective estrogen receptor modulator, induces mitochondria-mediated apoptosis in human endometrial carcinoma cells. (18807138)
Morishima S.... Otsuki Y.
|25|Imup-1 and imup-2 overexpression in endometrial carcinoma in Korean and Japanese populations. (18507030)
Kim S.J.... Kim J.K.
|26|Expression of retinoic acid receptors in human endometrial carcinoma. (18271925)
Tanabe K.... Yaegashi N.
|27|Endometrial carcinoma: pathology and genetics. (17365824)
Prat J.... CatasA_s L.
|28|Expression of LIV-1 mRNA in human cervical carcinoma and endometrial carcinoma]. (17959546)
Zhao L.... Li X.
|29|Increased expression of hypoxia-inducible factor 1alpha in type I and type II endometrial carcinomas. (17099695)
Pansare V.... Ali-Fehmi R.
|30|Proteasome inhibitors induce death but activate NF-kappaB on endometrial carcinoma cell lines and primary culture explants. (16735506)
Dolcet X.... Matias-Guiu X.
|31|Comparison of letrozole and exemestane used in non-adjuvant therapy of endometrial carcinoma]. (15909811)
BershteA-n L.M.... Thijssen J.H.
|32|High serum levels of interleukin-6 in endometrial carcinoma are associated with uterine serous papillary histology, a highly aggressive and chemotherapy-resistant variant of endometrial cancer. (15904949)
Bellone S.... Santin A.D.
|33|Expression of cancer-testis antigens in endometrial carcinomas using a tissue microarray. (15272278)
Chitale D.A.... Soslow R.A.
|34|S100 as an immunohistochemically-detected marker with prognostic significance in endometrial carcinoma. (16033094)
Honig A.... Kammerer U.
|35|A significance of immunohistochemical determination of steroid receptors, cell proliferation factor Ki-67 and protein p53 in endometrial carcinoma. (15047211)
Oreskovic S.... Beketic-Oreskovic L.
|36|VEGF expression and its reguration by p53 gene transfection in endometrial carcinoma cells. (12971625)
Fujisawa T.... Kuramoto H.
|37|A phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study. (10926805)
Rose P.G.... Lee R.B.
|38|PTEN mutations in endometrial carcinomas: a molecular and clinicopathologic analysis of 38 cases. (10746673)
Bussaglia E.... Prat J.
|39|Molecular and cytokinetic pretreatment risk assessment in endometrial carcinoma. (10739683)
Silverman M.B.... Podratz K.C.
|40|Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma. (10053103)
Nola M.... MarusiA8 M.
|41|Determination of a normal level of serum CA125 in postmenopausal women as a tool for preoperative evaluation and postoperative surveillance of endometrial carcinoma. (9648586)
Kurihara T.... Nishimura T.
|42|Differential inhibitory effects on human endometrial carcinoma cell growth of luteinizing hormone-releasing hormone analogues. (9887238)
Borri P.... Mini E.
|43|Bcl-2 and p53 expression in stage I endometrial carcinoma. (9854478)
Giatromanolaki A.... Gatter K.C.
|44|Expression of pS2 protein in endometrial carcinomas: correlation with clinicopathologic features and sex steroid receptor status. (9221798)
Koshiyama M.... Tauchi K.
|45|Gi protein activation of gonadotropin-releasing hormone-mediated protein dephosphorylation in human endometrial carcinoma. (9065184)
Imai A.... Tamaya T.
|46|Mutational analysis of the BRCA1 tumor suppressor gene in endometrial carcinoma. (9299260)
Liu F.S.... Shih A.
|47|Overexpression of p53 protein is an independent prognostic indicator in human endometrial carcinoma. (8761370)
Soong R.... Iacopetta B.J.
|48|Decreased E-cadherin expression in endometrial carcinoma is associated with tumor dedifferentiation and deep myometrial invasion. (8188077)
Sakuragi N.... Fujimoto S.
|49|Presence of gonadotropin-releasing hormone receptor and its messenger ribonucleic acid in endometrial carcinoma and endometrium. (7959256)
Imai A.... Tamaya T.
|50|Aromatase activity and the effect of estradiol and testosterone on DNA synthesis in endometrial carcinoma cell lines. (8476779)
Tada A.... Terashima Y.